Others

Code of Conduct of Fair Disclosure

| Updated on May 16, 2015 Published on May 16, 2015

Aurobindo Pharma Ltd has submitted to BSE the Code of Practices and Procedures for Fair Disclosure of Un-Published Price Sensitive Information formulated pursuant to the provisions of Regulation 8 of SEBI (Prohibition of Insider Trading) Regulations, 2015 which has been approved by the Board of Directors of the Company.

Pdf Link: >Code of Conduct of Fair Disclosure

Source : BSE - >www.bseindia.com

Published on May 16, 2015
This article is closed for comments.
Please Email the Editor